Basic Responsive HTML5
  • Hiring
  • About
    • Corporate Overview
    • Founder
    • Management
    • Scientific Advisory Board
    • Board of Directors
    • Board of Advisors
    • Partnerships
    • Contact
  • Videos
    • CEO Updates
    • News
    • Patient Testimonials
  • Technology
    • Technology Overview
    • Manufacturing
    • Intellectual Property
    • Publications
  • Clinical Pipeline
    • ACP-01 Phase II Clinical Trial for CLI
    • Platform
    • Critical Limb Ischemia
  • News & Media
    • News / Press Releases
    • Blog
  • Investor
    • Investor Presentations
    • One Page Overview
    • Analysts
    • Public Filings
    • AGM Materials
MENU ≡
  • Hiring
  • About
    • Corporate Overview
    • Founder
    • Management
    • Scientific Advisory Board
    • Board of Directors
    • Board of Advisors
    • Partnerships
    • Contact
  • Videos
    • CEO Updates
    • News
    • Patient Testimonials
  • Technology
    • Technology Overview
    • Manufacturing
    • Intellectual Property
    • Publications
  • Clinical Pipeline
    • ACP-01 Phase II Clinical Trial for CLI
    • Platform
    • Critical Limb Ischemia
  • News & Media
    • News / Press Releases
    • Blog
  • Investor
    • Investor Presentations
    • One Page Overview
    • Analysts
    • Public Filings
    • AGM Materials

Management

Thomas A. Smeenk

President & CEO, Co-Founder

Dr. Fraser Henderson

Chief Medical Officer

Dr. Mary Argent-Katwala

Manager, Clinical Trials

Peter Pavlin

Vice President of Operations

  • Contact
  • Safe Harbour

Copyright © 2023 Hemostemix Inc. All rights reserved.